Sterile Injectable Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2028

Jan 2018| TMR098A| Transparency

Report Highlights

REPORT DESCRIPTION

This report on sterile injectable drugs market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing sterile injectable drugs products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global sterile injectable drugs market with respect to the leading market segments based on major types, applications, usage, end users, and geographies.

Based on the product type, the sterile injectable drugs market has been segmented into: small and large molecules. In term of indication, it can be segmented into cardiology & metabolic disorders, neurology, oncology, autoimmune, gastroenterology, hematology, pain, infectious diseases and others. On the basis of drug class it can be segmented into monoclonal antibodies, cytokines, peptide hormones, vaccines, peptide antibiotics, insulin, blood factors, immunoglobulin and others,. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, technological advancement, and growing number of use of disposable products in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the sterile injectable drugs market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global sterile injectable drugs market.

Geographically, sterile injectable drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global sterile injectable drugs market.

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global sterile injectable drugs market. The report also profiles key players operating in the sterile injectable drugs market which are Baxter International Inc., Sanofi, Pfizer Inc., and GlaxoSmithKline plc. AstraZeneca, Gilead, Sciences, Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., and Novo Nordisk A/S. The global sterile injectable drugs market is dominated by two global vendors that accounts for around 80% share of the global market.

The global sterile injectable drugs market is segmented as follows:

Global Sterile Injectable Drugs Market, by Type

Small Molecule
Large Molecule
Global Sterile Injectable Drugs Market, by Drug Class

Monoclonal Antibodies (Mabs)
Cytokines
Insulin
Peptide Hormones
Vaccine
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
Global Sterile Injectable Drugs Market, by By Indication

Cardiology & Metabolic disorders
Neurology
Oncology
Autoimmune
Gastroenterology
Hematology
Pain
Infectious diseases
Others
Global Sterile Injectable Drugs Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
E-commerce
Global Sterile Injectable Drugs Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of the Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Pipeline Analysis
  • Table 2 : Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
  • Table 3 : Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
  • Table 4 : Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Indication, 2017–2025
  • Table 5 : Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
  • Table 6 : Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Region Type, 2015–2025
  • Table 7 : North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
  • Table 8 : North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
  • Table 9 : North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
  • Table 10 : North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
  • Table 11 : North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
  • Table 12 : Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
  • Table 13 : Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
  • Table 14 : Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
  • Table 15 : Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
  • Table 16 : Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
  • Table 17 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
  • Table 18 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
  • Table 19 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
  • Table 20 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
  • Table 21 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
  • Table 22 : Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
  • Table 23 : Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
  • Table 24 : Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
  • Table 25 : Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
  • Table 26 : Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
  • Table 27 : Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
  • Table 28 : Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
  • Table 29 : Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
  • Table 30 : Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
  • Table 31 : Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
  • Figure 1 : Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, 2015–2025
  • Figure 2 : Global Sterile Injectable Drugs Market Value Share Analysis by Type, 2017 and 2025
  • Figure 3 : Global Sterile Injectable Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015–2025
  • Figure 4 : Global Sterile Injectable Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015–2025
  • Figure 5 : Sterile Injectable Drugs Market Attractiveness Analysis by Type
  • Figure 6 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Monoclonal Antibodies, 2015–2025
  • Figure 7 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Cytokines, 2015–2025
  • Figure 8 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Insulin, 2015–2025
  • Figure 9 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Peptide Hormones, 2015–2025
  • Figure 10 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Vaccine, 2015–2025
  • Figure 11 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Immunoglobulin, 2015–2025
  • Figure 12 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Blood Factors, 2015–2025
  • Figure 13 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Peptide Antibiotics, 2015–2025
  • Figure 14 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Others, 2015–2025
  • Figure 15 : Global Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025 Content
  • Figure 16 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Cardiology & Metabolic disorders, 2015–2025
  • Figure 17 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Neurology, 2015–2025
  • Figure 18 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Oncology, 2015–2025
  • Figure 19 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Autoimmune, 2015–2025
  • Figure 20 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Gastroenterology, 2015–2025
  • Figure 21 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Hematology, 2015–2025
  • Figure 22 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Pain, 2015–2025
  • Figure 23 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Infectious diseases, 2015–2025
  • Figure 24 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Others, 2015–2025
  • Figure 25 : Global Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
  • Figure 26 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Hospital Pharmacy, 2015–2025
  • Figure 27 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Retail Pharmacy, 2015–2025
  • Figure 28 : Global Sterile Injectable Drugs Market Revenue (US$ Bn), by E-commerce, 2015–2025
  • Figure 29 : Global Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 30 : Global Sterile Injectable Drugs Market Value Share Analysis by Region Type, 2017 and 2025
  • Figure 31 : Sterile Injectable Drugs Market Attractiveness Analysis, by Region Type
  • Figure 32 : North America Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 33 : North America Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 35 : North America Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 36 : North America Market Value Share Analysis by Type, 2016 and 2025
  • Figure 37 : North America Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 38 : North America Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 39 : North America Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 40 : North America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
  • Figure 41 : North America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
  • Figure 42 : North America Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
  • Figure 43 : North America Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
  • Figure 44 : Europe Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 45 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 46 : Europe Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 47 : Europe Market Value Share Analysis by Type, 2016 and 2025
  • Figure 48 : Europe Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 49 : Europe Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 50 : Europe Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 51 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
  • Figure 52 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
  • Figure 53 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
  • Figure 54 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
  • Figure 55 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 56 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 57 : Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 58 : Asia Pacific Market Value Share Analysis by Type, 2016 and 2025
  • Figure 59 : Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 60 : Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 61 : Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 62 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
  • Figure 63 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
  • Figure 64 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
  • Figure 65 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
  • Figure 66 : Latin America Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 67 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 68 : Latin America Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 69 : Latin America Market Value Share Analysis by Type, 2016 and 2025
  • Figure 70 : Latin America Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 71 : Latin America Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 72 : Latin America Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 73 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
  • Figure 74 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
  • Figure 75 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
  • Figure 76 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
  • Figure 77 : Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 78 : Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 79 : Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 80 : Middle East & Africa Market Value Share Analysis by Type, 2016 and 2025
  • Figure 81 : Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
  • Figure 82 : Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
  • Figure 83 : Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
  • Figure 84 : Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
  • Figure 85 : Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
  • Figure 86 : Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
  • Figure 87 : Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
  • Figure 88 : Heat Map Analysis by Company (2016)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report